SURGICAL TREATMENT CHOICE FOR PATIENTS WITH NON-RESECTABLE PANCREATIC HEAD CANCER
ARTICLE PDF

Keywords

pancreatic head cancer
obstructive jaundice
stenting of the biliary system

How to Cite

Bezrodnyi, B. H., Kolosovych, I. V., & Nesteruk, Y. O. (2025). SURGICAL TREATMENT CHOICE FOR PATIENTS WITH NON-RESECTABLE PANCREATIC HEAD CANCER. Clinical and Preventive Medicine, (1), 31-41. https://doi.org/10.31612/2616-4868.1.2025.04

Abstract

Introduction. Due to the late diagnosis of the pancreatic head cancer, up to 80% of patients are subjected only to palliative surgical treatment to eliminate complications, i.e., obstructive jaundice and stenosis of the duodenum by a tumor, through a hepaticojejunostomy or transpapillary stenting of the common bile duct with self-expanding metal stents (SEMS). The disadvantages of open surgery include a high incidence of postoperative complications and mortality, and those of the transpapillary stenting – obstruction of up to 40% of stents in 6-8 years after implantation. With modern polychemotherapy, the survival rate of patients exceeds a year, when the drainage function of stents is impaired, and surgical bypass functions without complications. Therefore, it is relevant to personalize the choice of treatment for the patients.

Aim. To improve the results of palliative surgical treatment of patients with unresectable pancreatic head cancer, complicated by obstructive jaundice, by improving the choice of methods and techniques of surgical interventions.

Materials and methods. The randomized prospective study is based on the analysis of the obstructive jaundice treatment outcomes after the Roux hepaticojejunostomy with prophylactic gastrojejunostomy (main group, 53 patients) or transpapillary stenting of the common bile duct with SEMS (study group, 54 patients) were performed. The authors evaluated the effect of multiple organ failure and the Karnofsky index on the choice of patient treatment strategy, on the immediate and remote results, as well as the quality of life of patients in the postoperative period, using the EORTC QLQ-C30 V.3 and EORTC QLQ-PAN26 questionnaires.

Results. The use of self-expanding metal stents for internal drainage of the biliary system, compared with open surgery of double bypass reduces the incidence of postoperative complications by 29.9% (χ2=13.7, 95% CI 14.38-44.08, p=0.0002), and mortality by 7. 5% (χ2=4.16, 95% CI - 0.05-17.79, p=0.04). However, the course of the remote postoperative period (from 8 to 11 months) is complicated in 11.1% of cases by acute, in 37.1% by chronic recurrent cholangitis, and in 7.4% of cases an obstructive duodenal obstruction develops, which deteriorates the quality of patients’ lives, and requires re-hospitalization and reconstructive interventions.

Conclusions. With a Karnofsky index <80, it is advisable to perform stenting of the common bile duct with SEMS, with a Karnofsky index >80, double biliodigestive and prophylactic gastrodigestive bypass surgery should be performed. When multiorgan dysfunction and cholangitis develop against the obstructive jaundice, the treatment consists of two stages, the first – transpapillary biliary drainage with plastic stents, the second – elective surgical intervention.

https://doi.org/10.31612/2616-4868.1.2025.04
ARTICLE PDF

References

Beger H.G., Büchler M.W., Hruban R.H. (2023). The Pancreas: An Integrated Textbook of Basic Science, Medicine, and Surgery, Fourth Edition, Wiley Blackwell, USA, 1340 p.

Neoptolemos J.P., Urrutia R., Abbruzzese J.L., Büchler M.W. (2018). Pancreatic Cancer. Second Edition/ Springer, P. 857- 873.

Bezrodnyi B.H, Kolosovych I.V., Hanol I.V., Cherepenko I.V, Slobodianyk VP, Lebedieva K.O. (2023). Palliative surgical treatment of patients with unresectable cancer of the head of the pancreas complicated by mechanical jaundice. Wiad Lek., 76(4), 703-708. https://doi:10.36740/WLek202304102

Ying-bin Liu, Ed. (2020). Surgical Atlas of Pancreatic Cancer Springer, Nature Singapore Pte Ltd., 239 p.

Pencovich N. Orbach L., Lessing Y. (2020). Palliative bypass surgery for patients with advanced pancreatic adenocarcinoma: experience from a tertiary center. World Journal of Surgical Oncology, 18, 63, P. 1-6. https://doi.org/10.1186/s12957-020-01828-5

Christoph Springfeld, Thomas Seufferlein (2023). Palliative Chemotherapy for Advanced Pancreatic Cancer: Treatment Modalities, Side-effects, and Benefits of Survival. In: The Pancreas; An Integrated Textbook of Basic Science, Medicine, and Surgery, Fourth Edition. P. 1196-1200.

Zaivelyova Yu.I. (2023). New treatment options for pancreatic skin cancer. Practical Oncology, 6, 1, 13-15. DOI: https://doi.org/10.22141/2663-3272.6.1.2023.79

Lillemoe K.D., Cameron J.L., Kaufman H.S. (1993). Chemical splanchnicectomy in patients with unresectable pancreatic cancer. A prospective randomized trial. Annals of Surgery, 217, 5, 447-457.

Satava R. M. (2005). Identification and reduction of surgical error using simulation, Minimally Invasive Therapy and Allied Technologies. 14, 4-5, 257–261, 2-s2.0-27744548685. https://doi.org/10.1080/13645700500274112.

Dindo D., Demartines N., Clavien P. A. Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey // Ann. Surg. 2004. Vol. 240, №2. P. 205.

Clavien P.A., Barkun J., Oliveira M.L., Dindo D. (2009). The Clavien-Dindo Classification of Surgical Complications. Five-Year Experience. Annals of Surgery, 250, 2, P.187-196

Bolliger M., Kroehnert J.A., Molineus F., Kandioler D., Schindl M., Riss P. (2018). Experiences with the standardized classification of surgical complications (Clavien-Dindo) in general surgery patients. Eur Surg., 50(6), 256-261. doi:10.1007/s10353-018-0551-z

Strasberg S. M., Linehan D. C., Hawkins W. G. (2009). The accordion severity grading system of surgical complications. Ann. Surg., 250, 2, 177–186.

EORTC QLQ-C30 Scoring Manual (2001). Third edition, Brussels, Belgium,78 р.

Tara M. Mackay, Willemieke P.M. (2022). The impact of cancer treatment on quality of life in patients with pancreatic and periampullary cancer: a propensity score matched analysis. Hepato-Pancreato-Biliary Association Inc., 24, 443–451. https://doi.org/10.1016/j.hpb.2021.09.003

Eaton Anne A, Karanicolas Paul (Jan 2017). Psychometric Validation of the EORTC QLQ-PAN26 Pancreatic Cancer Module for Assessing Health Related Quality of Life after Pancreatic Resection. Journal of the Pancreas, 18, 1, 19-25

Zhi Ven, Yurie Sekigami (2021). Assessment of the Long-Term Impact of Pancreatoduodenectomy on Health-Related Quality of Life Using the EORTC QLQ-PAN26 Module. Ann Surg Oncol, 28, 4216–4224.

Guideline for Estimating Length of Survival in Palliative Patients (Aug 05, 2005). Prognostic scoring The Karnofski, Palliative Performance Scale (PPS) and Palliative Prognostic Indicator (PPI). Prognostic scoring paper GSF website.

Wilcox C.M, Kim H., Seay T. (2015). Choice of plastic or metal stent for patients with jaundice with pancreaticobiliary malignancy using simple clinical tools: a prospective evaluation. BMJ Open Gastro, 2, e000014. doi:10.1136/bmjgast-2014-000014

Бойко В.В., Польовий В.П., Смачило Р.М. (2023). Патогенетична класифікація холангіту. Харківська хірургічна школа, 1–2, 6-10.

Bezrodnyi B.H., Kolosovych I.V., Hanol I.V., Cherepenko I.V., Slobodianyk V.P., Nesteruk Y.O. (2024). Comparison of the clinical effectiveness of hepaticojejunostomy and self-expanding metal stents for bypassing the bile ducts in patients with unresectable pancreatic head cancer complicated by obstructive jaundice. Wiad Lek., 77(4), 629-634. doi: 10.36740/WLek202404102. PMID: 38865614.

Fábián A., Bor R., Gede N., Bacsur P., Pécsi D., Hegyi P., Tóth B., Szakács Z., Vincze Á., Ruzsics I., Rakonczay Z. Jr, Erőss B., Sepp R., Szepes Z. (2020 Apr). Double Stenting for Malignant Biliary and Duodenal Obstruction: A Systematic Review and Meta-Analysis. Clin Transl Gastroenterol., 11(4), e00161. doi: 10.14309/ctg.0000000000000161

Кучин, Ю.Л., Безродний, Б.Г., Колосович, І.В., Слободяник, В.П. (2024) Паліативне хірургічне лікування раку підшлункової залози. Київ: Видавець Бихун В.Ю., 456 с.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.